We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's lead asset is KVA12.1, a VISTA blocking immunotherapy. Kineta Inc is a clinical-stage biotechnology company with a mission to develop next generation immunotherapies that transform patients' lives. The company's lead asset is KVA12.1, a VISTA blocking immunotherapy.
Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts Favorable clinical safety and tolerability profile observed with no...
Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohorts in the VISTA-101 trial No dose limiting toxicities observed at any...
Partial response and stable disease reported in combination cohort, and durable stable disease observed in monotherapy cohortsNo dose limiting toxicities observed at any dose levelCleared fifth of...
SEATTLE, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.036 | -5.75171752676 | 0.6259 | 0.6299 | 0.5001 | 92141 | 0.5748234 | CS |
4 | 0.0317 | 5.67896811179 | 0.5582 | 0.7399 | 0.3339 | 869362 | 0.50627156 | CS |
12 | -1.8201 | -75.5228215768 | 2.41 | 2.83 | 0.3339 | 405513 | 0.5957363 | CS |
26 | -3.8251 | -86.6387315968 | 4.415 | 4.9 | 0.3339 | 199760 | 0.74140541 | CS |
52 | -3.5601 | -85.7855421687 | 4.15 | 5.39 | 0.3339 | 111303 | 0.97675524 | CS |
156 | -8.2901 | -93.356981982 | 8.88 | 9 | 0.3339 | 90791 | 1.39393205 | CS |
260 | -8.2901 | -93.356981982 | 8.88 | 9 | 0.3339 | 90791 | 1.39393205 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions